Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Tris Pharma appoints new Vice President of Business Development

Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, announced the appointment of Jonathan Berlent as Vice President of Business Development.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

 He will lead Tris' product and technology partnering, and collaborate with branded pharmaceutical companies on their life cycle management opportunities.

"As Tris scales up its effort to address the growing unmet need in the industry for liquid extended release technology, Jonathan will lead business development efforts and be our point person with branded pharmaceutical companies," said Ketan Mehta, President and CEO of Tris Pharma.  "With Jonathan leading business development, Peter Ciano will focus on strategy and corporate development activities including acquisitions."

"Tris is a pioneer in commercializing unique, sustained release formulations such as oral liquid suspensions, orally disintegrating tablets and chewable tablets that do not require patients to swallow a pill," said Berlent. "I am truly excited to be part of the Tris management team and look forward to leading business development efforts."

Jonathan brings to Tris a combination of pharmaceutical and securities industry experience.  For the past nine years, he has held various senior leadership positions in the pharmaceutical industry.  Most recently, he was President of Granules USA, Inc., where he led its North American operations and successfully launched a finished dosage business platform working with such companies as Pfizer, Novartis, McNeil Consumer Health Janssen, GlaxoSmithKline, Par and Perrigo.  He began his career in the capital markets at Bank of America.  He is an alumnus of the University of Michigan and has an MBA from NYU Stern School of Business, where he majored in finance and management.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?